A Post-marketing, Observational, Retrospective Study to Assess the Safety of RefortrixTM (Tdap) When Administered During Pregnancy in a Maternal Immunization Program in Brazil.
Clinical trial NCT02757950 · COMPLETED
Trial details
- NCT number
- NCT02757950
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2016-07-14
- Primary completion
- 2017-05-31
- Enrollment
- 2462
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.